Advertisement

Psychopharmacological Principles

  • Susan Solimine
  • Anthony P. S. Guerrero
Chapter

Abstract

It is important to understand that the use of psychopharmacology in the pediatric population is not necessarily the same as in adults. Child and adolescent psychiatrists will often say that children are “not just small adults,” and therefore the treatment choices and dosages may be similar or different to those used in adults. Additionally, we must acknowledge that data on the usage of psychotropic medications in children is limited, and many commonly used agents are not necessarily approved by national regulatory organizations for use in this population. Providers may, at times, use psychotropic medications “off-label” to target specific treatment needs of the patient while maintaining the standard of care.

Keywords

Pediatric psychopharmacology Pediatric psychosomatic medicine Psychiatric consultation-liaison Cancer and depression management Respiratory illnesses and mental health Depression in medically ill children Anxiety in medically ill children 

References

  1. Guerrero, A. P. S., & Matsu, C. R. (2007). Chapter 24: Children and adolescents. In H. Leigh & J. Streltzer (Eds.), Handbook of consultation-liaison psychiatry (pp. 316–340). New York: Springer.CrossRefGoogle Scholar
  2. Indiana University School of Medicine Department of Medicine Clinical Pharmacology. P450 Interaction Table. http://medicine.iupui.edu/clinpharm/ddis/main-table. Accessed 1 Jan 2018.
  3. Levenson, J. L. (2007). Psychiatric issues in pulmonary disease. Primary Psychiatry, 14(3), 25–28.Google Scholar
  4. Minds Matter Ohio Psychotropic Medical Quality Improvement Collaborative. Psychotropic medication list. http://www.ohiomindsmatter.org/documents/Psychotropic%20Medication%20List.pdf. Accessed 1 Jan 2018.
  5. Oliveira, L., & Santos, Z. (2015). Uses of psychotropics and drug-drug interactions in oncology: Reflections from a study in a Portuguese psycho-oncology unit. Advances in Pharmacoepidemiology and Drug Safety, 4(5), 194.Google Scholar
  6. Pao, M., et al. (2006). Psychotropic medication use in pediatric patients with cancer. Archives of Pediatrics & Adolescent Medicine, 160(August), 818–824.CrossRefGoogle Scholar
  7. Thom, R. P. (2017). Pediatric delirium. American Journal of Psychiatry, Residents Journal, 12(2), 6–8.CrossRefGoogle Scholar
  8. Turkel, S. B., Jacobson, J., Munzig, E., et al. (2012). Atypical antipsychotic medications to control symptoms of delirium in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 22(2), 126–130.CrossRefPubMedGoogle Scholar
  9. Vitiello B. (2012). Principles in using psychotropic medication in children and adolescents. In J. M. Rey (Ed.), IACAPAP e-textbook of child and adolescent mental health. Geneva: International Association for Child and Adolescent Psychiatry and Allied Professions http://iacapap.org/iacapap-textbook-of-child-and-adolescent-mental-health. Accessed 1 Jan 2018.

Further Readings

  1. Birmaher, B., & Brent, D. (2007). Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 46(11, , November), 1503–1526.CrossRefGoogle Scholar
  2. Bursch, B., & Forgey, M. (2013). Psychopharmacology for medically ill adolescents. Current Psychiatry Reports, 15, 395.CrossRefPubMedGoogle Scholar
  3. Chadwick, B., et al. (2005). Potentially hazardous drug interactions with psychotropics. Advances in Psychiatric Treatment, 11, 440–449.CrossRefGoogle Scholar
  4. Connolly, S. D., & Bernstein, G. A. (2007). Practice parameter for the assessment and treatment of child and adolescents with anxiety disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 46(2, February), 267–283.Google Scholar
  5. Connor, D. F., & Meltzer, B. M. (2006). Pediatric psychopharmacology: Fast facts. New York: W. W. Norton.Google Scholar
  6. Findling, R. L., Drury, S. S., Jensen, P. S., & Rapoport, J. (2011). Practice parameter for the use of atypical antipsychotic medications in children and adolescents. Not yet published in Journal of the American Academy of Child & Adolescent Psychiatry, updated in 2011.Google Scholar
  7. Lavid, N., & Budner, L. J. (2000). Review of the pharmacological treatment of delirium in the pediatric population with accompanying protocol. Jefferson Journal of Psychiatry, 15, 25–33.14.CrossRefGoogle Scholar
  8. Schieveld, J. N., et al. (2007). Pediatric delirium in critical illness: Phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Medicine, 33(6), 1033–1040.CrossRefPubMedPubMedCentralGoogle Scholar
  9. Walkup, J. (2009, September). Practice parameter on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 48(9), 961.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PsychiatryTripler Army Medical Center, CAFBHSHonoluluUSA
  2. 2.Department of PsychiatryUniversity of Hawai‘i John A. Burns School of MedicineHonoluluUSA

Personalised recommendations